Finite element analysis of fibrous tissue morphogenesis : a study of the osteogenic index using a biphasic approach

An axisymmetric finite element model of the soft gap tissue and surrounding cancellous bone was developed to analyse the biomechanical behaviour of the environment surrounding the implant. Both isotropic linear and biphasic representations of constitutive behaviour for the tissues were considered. The biphasic approach models the tissue as a control system of a solid and a fluid "perfusant". The work presented assumes a technological significance for rational design of load bearing implants

Advances in transcatheter mitral and tricuspid therapies

BACKGROUND: While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need. The advent of transcatheter therapies offer new treatment options to often elderly and frail patients at high risk for open surgery. We aimed at providing an updated review of fast-growing domain of transcatheter mitral and tricuspid technology. MAIN BODY: We reviewed the existing literature on mitral and tricuspid transcatheter therapies. Mitraclip is becoming an established therapy for secondary mitral regurgitation in selected patients with disproportionately severe regurgitation associated with moderate left ventricle dysfunction. Evidence is less convincing for primary mitral regurgitation. Transcatheter mitral valve replacement is a promising emerging alternative to transcatheter repair, for secondary as well as primary mitral regurgitation. But further development is needed to improve delivery. Transcatheter tricuspid intervention arrives late after similar technologies have been developed for aortic and mitral valves and is currently at its infancy. This is likely due in part to previously under-recognized impact of tricuspid regurgitation on patient outcomes. Edge-to-edge repair is the most advanced transcatheter solution in development. Data on tricuspid annuloplasty and replacement is limited, and more research is warranted. CONCLUSION: The future appears bright for transcatheter mitral therapies, albeit their place in clinical practice is yet to be clearly defined. Tricuspid transcatheter therapies might address the unmet need of tricuspid regurgitation treatment

Coronal mass ejections as expanding force-free structures

We mode Solar coronal mass ejections (CMEs) as expanding force-fee magnetic structures and find the self-similar dynamics of configurations with spatially constant \alpha, where {\bf J} =\alpha {\bf B}, in spherical and cylindrical geometries, expanding spheromaks and expanding Lundquist fields correspondingly. The field structures remain force-free, under the conventional non-relativistic assumption that the dynamical effects of the inductive electric fields can be neglected. While keeping the internal magnetic field structure of the stationary solutions, expansion leads to complicated internal velocities and rotation, induced by inductive electric field. The structures depends only on overall radius R(t) and rate of expansion \dot{R}(t) measured at a given moment, and thus are applicable to arbitrary expansion laws. In case of cylindrical Lundquist fields, the flux conservation requires that both axial and radial expansion proceed with equal rates. In accordance with observations, the model predicts that the maximum magnetic field is reached before the spacecraft reaches the geometric center of a CME.Comment: 19 pages, 9 Figures, accepted by Solar Physic

Whole-genome sequencing reveals host factors underlying critical COVID-19

Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic variation influences the development of illness requiring critical care1 or hospitalization2,3,4 after infection with SARS-CoV-2. The GenOMICC (Genetics of Mortality in Critical Care) study enables the comparison of genomes from individuals who are critically ill with those of population controls to find underlying disease mechanisms. Here we use whole-genome sequencing in 7,491 critically ill individuals compared with 48,400 controls to discover and replicate 23 independent variants that significantly predispose to critical COVID-19. We identify 16 new independent associations, including variants within genes that are involved in interferon signalling (IL10RB and PLSCR1), leucocyte differentiation (BCL11A) and blood-type antigen secretor status (FUT2). Using transcriptome-wide association and colocalization to infer the effect of gene expression on disease severity, we find evidence that implicates multiple genes—including reduced expression of a membrane flippase (ATP11A), and increased expression of a mucin (MUC1)—in critical disease. Mendelian randomization provides evidence in support of causal roles for myeloid cell adhesion molecules (SELE, ICAM5 and CD209) and the coagulation factor F8, all of which are potentially druggable targets. Our results are broadly consistent with a multi-component model of COVID-19 pathophysiology, in which at least two distinct mechanisms can predispose to life-threatening disease: failure to control viral replication; or an enhanced tendency towards pulmonary inflammation and intravascular coagulation. We show that comparison between cases of critical illness and population controls is highly efficient for the detection of therapeutically relevant mechanisms of disease

Biophysical stimuli on cells during tissue differentiation at implant interfaces

Contains fulltext : 25371.PDF (publisher's version ) (Open Access